Last updated: 18 March 2024 at 7:51pm EST

Jeffrey Dierks M.B.A. Net Worth




The estimated Net Worth of Jeffrey Dierks is at least $1.4 Million dollars as of 15 March 2024. Mr Dierks owns over 11,979 units of Harmony Biosciences stock worth over $446,577 and over the last 4 years he sold HRMY stock worth over $340,976. In addition, he makes $613,877 as Exec. VP & Chief Commercial Officer at Harmony Biosciences.

Mr A HRMY stock SEC Form 4 insiders trading

Mr has made over 13 trades of the Harmony Biosciences stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 11,979 units of HRMY stock worth $98,467 on 15 March 2024.

The largest trade he's ever made was exercising 28,971 units of Harmony Biosciences stock on 22 August 2022 worth over $695,304. On average, Mr trades about 8,373 units every 59 days since 2020. As of 15 March 2024 he still owns at least 11,979 units of Harmony Biosciences stock.

You can see the complete history of Mr Dierks stock trades at the bottom of the page.





Mr. Jeffrey Dierks M.B.A. biography

Jeffrey Dierks M.B.A. is the Exec. VP & Chief Commercial Officer at Harmony Biosciences.

What is the salary of Mr A?

As the Exec. VP & Chief Commercial Officer of Harmony Biosciences, the total compensation of Mr A at Harmony Biosciences is $613,877. There are 2 executives at Harmony Biosciences getting paid more, with John Charles Jacobs M.B.A. having the highest compensation of $933,938.



How old is Mr A?

Mr A is 49, he's been the Exec. VP & Chief Commercial Officer of Harmony Biosciences since . There are 4 older and 1 younger executives at Harmony Biosciences. The oldest executive at Harmony Biosciences Holdings, Inc. is Dr. Jeffrey M. Dayno M.D., 64, who is the Chief Medical Officer.

Insiders trading at Harmony Biosciences

Over the last 4 years, insiders at Harmony Biosciences have traded over $224,163,932 worth of Harmony Biosciences stock and bought 514,681 units worth $12,537,009 . The most active insiders traders include Holdings A/S Novo, Andreas Wicki, and Antonio J. Gracias. On average, Harmony Biosciences executives and independent directors trade stock every 19 days with the average trade being worth of $2,907,691. The most recent stock trade was executed by Sandip Kapadia on 29 March 2024, trading 15,000 units of HRMY stock currently worth $559,200.



What does Harmony Biosciences do?

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.



What does Harmony Biosciences's logo look like?

Harmony Biosciences Holdings, Inc. logo

Complete history of Mr Dierks stock trades at Harmony Biosciences

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
15 Mar 2024 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Option 11,979 $8.22 $98,467
15 Mar 2024
11,979
8 Mar 2024 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Option 194 $8.22 $1,595
8 Mar 2024
194
3 Oct 2022 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Option 12,173 $8.22 $100,062
3 Oct 2022
12,173
22 Aug 2022 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Option 28,971 $24.00 $695,304
22 Aug 2022
28,971
1 Apr 2022 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Option 14,471 $24.00 $347,304
1 Apr 2022
14,471
28 Feb 2022 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Option 14,910 $18.85 $281,054
28 Feb 2022
4,869
16 Feb 2022 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Sale 8,518 $40.03 $340,976
16 Feb 2022
0
6 Jan 2022 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Option 6,125 $8.22 $50,348
6 Jan 2022
6,125
1 Nov 2021 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Option 10,000 $8.22 $82,200
1 Nov 2021
10,000
7 Sep 2021 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Option 5,000 $8.22 $41,100
7 Sep 2021
5,000
1 Sep 2021 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Option 10,000 $8.22 $82,200
1 Sep 2021
10,000
26 Aug 2021 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Option 5,000 $8.22 $41,100
26 Aug 2021
3,400
15 Jun 2021 Jeffrey Dierks
CHIEF COMMERCIAL OFFICER
Option 15,000 $8.22 $123,300
15 Jun 2021
15,000


Harmony Biosciences executives and stock owners

Harmony Biosciences executives and other stock owners filed with the SEC include: